Framework agreement with a single company, per batch, establishing the conditions for the supply of successive tracts and unit prices for vaccines intended for the Andalusian Vaccination Programme (PVA): diphtheria-tetanus-acellular pertussis with reduced antigen content, chickenpox, and adult hepatitis B (No. 2203/2023-No. SIGLO 663/2023).